{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:49:01Z","timestamp":1795016941049,"version":"4.10.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chronic respiratory diseases (CRDs) are the third leading cause of death worldwide. Data of the associations between specific volatile organic compounds (VOCs), a major component of air pollution and tobacco smoke, and subsequent CRD mortality in the general population are scarce.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In a case-cohort analysis within the population-based Golestan cohort study (<jats:italic>n<\/jats:italic>\u2009=\u200950045, aged 40\u201375 years, 58% women, enrollment: 2004\u20132008, northeastern Iran), we included all participants who died from CRD during follow-up through 2018 (<jats:italic>n<\/jats:italic>\u2009=\u2009242) as cases and stratified them into 16 strata defined by age, sex, residence, and tobacco smoking. Subcohort participants (<jats:italic>n<\/jats:italic>\u2009=\u2009610) were randomly selected from all eligible cohort participants in each stratum, and sampling fractions were calculated. Baseline urine samples were used to measure 20 VOCs using ultra high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. After excluding participants with previous history of CRDs, we used stratified Cox regression models weighted by the inverse sampling fractions (i.e. inverse probability weighting) adjusted for potential confounders, including urinary cotinine and pack-years of smoking, to calculate hazard ratios (HR) for the associations between biomarker tertiles and CRD mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Data from 545 non-case, sub-cohort participants and 149 cases (69.1% chronic obstructive pulmonary disease, 13.4% asthma, 17.5% other CRDs) were assessed in this study. During a follow-up of 10.5 years, associations [2nd and 3rd vs. 1st tertiles, HR (95% confidence interval), p for trend] were observed between metabolites of acrolein [1.56 (0.64,3.79), 3.53 (1.53,8.16), 0.002] and styrene\/ethylbenzene [1.17 (0.53,2.60), 3.24 (1.37,7.66), 0.005] and CRD mortality, which persisted after excluding the first four years of follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our findings support prior research suggesting respiratory toxicity of VOCs. Further investigation and monitoring of these compounds, especially acrolein and styrene\/ethylbenzene, as CRD risk factors, are recommended.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12931-025-03165-1","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T18:05:36Z","timestamp":1741197936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Exposure to volatile organic compounds and chronic respiratory disease mortality, a case-cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Mahdi","family":"Nalini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Poustchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.","family":"Blount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon M.","family":"Kenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy M.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Khoshnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Pourshams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell H.","family":"Gail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry I.","family":"Graubard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford M","family":"Dawsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farin","family":"Kamangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Boffetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian C.","family":"Abnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal D.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Etemadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"3165_CR1","unstructured":"Chronic respiratory diseases. World Health Organization. 2023. [Available at: https:\/\/www.who.int\/health-topics\/chronic-respiratory-diseases#tab=tab_1, accessed: 8 December 2023]."},{"key":"3165_CR2","doi-asserted-by":"publisher","first-page":"101936","DOI":"10.1016\/j.eclinm.2023.101936","volume":"59","author":"Global burden of chronic respiratory diseases and risk factors","year":"2023","unstructured":"Global burden of chronic respiratory diseases and risk factors. 1990\u20132019: an update from the global burden of disease study 2019. EClinicalMedicine. 2023;59:101936.","journal-title":"EClinicalMedicine"},{"issue":"10356","key":"3165_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(22)01273-9","volume":"400","author":"D Stolz","year":"2022","unstructured":"Stolz D, Mkorombindo T, Schumann DM, Agusti A, Ash SY, Bafadhel M, et al. Towards the elimination of chronic obstructive pulmonary disease: a lancet commission. Lancet. 2022;400(10356):921\u201372.","journal-title":"Lancet"},{"issue":"8","key":"3165_CR4","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1016\/S2213-2600(20)30329-5","volume":"8","author":"S Williams","year":"2020","unstructured":"Williams S, Sheikh A, Campbell H, Fitch N, Griffiths C, Heyderman RS, et al. Respiratory research funding is inadequate, inequitable, and a missed opportunity. Lancet Respir Med. 2020;8(8):e67\u20138.","journal-title":"Lancet Respir Med"},{"issue":"6377","key":"3165_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.aaq0524","volume":"359","author":"BC McDonald","year":"2018","unstructured":"McDonald BC, de Gouw JA, Gilman JB, Jathar SH, Akherati A, Cappa CD, et al. Volatile chemical products emerging as largest petrochemical source of urban organic emissions. Science. 2018;359(6377):760\u20134.","journal-title":"Science"},{"key":"3165_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.aca.2012.04.009","volume":"750","author":"KU Alwis","year":"2012","unstructured":"Alwis KU, Blount BC, Britt AS, Patel D, Ashley DL. Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI\/MSMS). Anal Chim Acta. 2012;750:152\u201360.","journal-title":"Anal Chim Acta"},{"key":"3165_CR7","unstructured":"U.S. Food and Drug Administration. Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke: Established List 2012 [Available from: https:\/\/www.fda.gov\/tobacco-products\/rules-regulations-and-guidance\/harmful-and-potentially-harmful-constituents-tobacco-products-and-tobacco-smoke-established-list, accessed: 8 December 2024.]."},{"issue":"5","key":"3165_CR8","doi-asserted-by":"publisher","first-page":"e13038","DOI":"10.1111\/ina.13038","volume":"32","author":"N Liu","year":"2022","unstructured":"Liu N, Bu Z, Liu W, Kan H, Zhao Z, Deng F, et al. Health effects of exposure to indoor volatile organic compounds from 1980 to 2017: A systematic review and meta-analysis. Indoor Air. 2022;32(5):e13038.","journal-title":"Indoor Air"},{"issue":"3","key":"3165_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/oem.60.3.227","volume":"60","author":"R McNamee","year":"2003","unstructured":"McNamee R. Confounding and confounders. Occup Environ Med. 2003;60(3):227\u201334. quiz 164, 234.","journal-title":"Occup Environ Med"},{"issue":"8","key":"3165_CR10","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1289\/ehp.9019","volume":"114","author":"L Elliott","year":"2006","unstructured":"Elliott L, Longnecker MP, Kissling GE, London SJ. Volatile organic compounds and pulmonary function in the third National health and nutrition examination survey, 1988\u20131994. Environ Health Perspect. 2006;114(8):1210\u20134.","journal-title":"Environ Health Perspect"},{"key":"3165_CR11","doi-asserted-by":"publisher","first-page":"107053","DOI":"10.1016\/j.rmed.2022.107053","volume":"205","author":"A Mendy","year":"2022","unstructured":"Mendy A, Burcham S, Merianos AL, Mersha TB, Mahabee-Gittens EM, Chen A, Yolton K. Urinary volatile organic compound metabolites and reduced lung function in U.S. Adults. Respir Med. 2022;205:107053.","journal-title":"Respir Med"},{"issue":"3","key":"3165_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1158\/1055-9965.EPI-22-1289","volume":"32","author":"A Etemadi","year":"2023","unstructured":"Etemadi A, Abnet CC, Dawsey SM, Freedman ND. Biomarkers of tobacco carcinogenesis in diverse populations: challenges and opportunities. Cancer Epidemiol Biomarkers Prev. 2023;32(3):289\u201391.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"3165_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/ije\/dyp161","volume":"39","author":"A Pourshams","year":"2010","unstructured":"Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, Sadjadi AR, et al. Cohort profile: the Golestan cohort Study\u2013a prospective study of oesophageal cancer in Northern Iran. Int J Epidemiol. 2010;39(1):52\u20139.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"3165_CR14","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/jat\/29.8.814","volume":"29","author":"JT Bernert","year":"2005","unstructured":"Bernert JT, Harmon TL, Sosnoff CS, McGuffey JE. Use of continine immunoassay test strips for preclassifying urine samples from smokers and nonsmokers prior to analysis by LC-MS-MS. J Anal Toxicol. 2005;29(8):814\u20138.","journal-title":"J Anal Toxicol"},{"issue":"2","key":"3165_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1158\/1055-9965.EPI-18-0743","volume":"28","author":"A Etemadi","year":"2019","unstructured":"Etemadi A, Poustchi H, Chang CM, Blount BC, Calafat AM, Wang L, et al. Urinary biomarkers of carcinogenic exposure among cigarette, waterpipe, and smokeless tobacco users and never users of tobacco in the Golestan cohort study. Cancer Epidemiol Biomarkers Prev. 2019;28(2):337\u201347.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"3165_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ije\/dyp195","volume":"38","author":"F Islami","year":"2009","unstructured":"Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, et al. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol. 2009;38(4):978\u201388.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"3165_CR17","doi-asserted-by":"publisher","first-page":"e11183","DOI":"10.1371\/journal.pone.0011183","volume":"5","author":"H Khademi","year":"2010","unstructured":"Khademi H, Etemadi A, Kamangar F, Nouraie M, Shakeri R, Abaie B, et al. Verbal autopsy: reliability and validity estimates for causes of death in the Golestan cohort study in Iran. PLoS ONE. 2010;5(6):e11183.","journal-title":"PLoS ONE"},{"issue":"12","key":"3165_CR18","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0895-4356(99)00102-X","volume":"52","author":"WE Barlow","year":"1999","unstructured":"Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol. 1999;52(12):1165\u201372.","journal-title":"J Clin Epidemiol"},{"key":"3165_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B"},{"key":"3165_CR20","doi-asserted-by":"publisher","first-page":"111864","DOI":"10.1016\/j.ecoenv.2020.111864","volume":"210","author":"H Kuang","year":"2021","unstructured":"Kuang H, Li Z, Lv X, Wu P, Tan J, Wu Q, et al. Exposure to volatile organic compounds May be associated with oxidative DNA damage-mediated childhood asthma. Ecotoxicol Environ Saf. 2021;210:111864.","journal-title":"Ecotoxicol Environ Saf"},{"key":"3165_CR21","doi-asserted-by":"publisher","first-page":"1210136","DOI":"10.3389\/fpubh.2023.1210136","volume":"11","author":"JJ Lv","year":"2023","unstructured":"Lv JJ, Li XY, Shen YC, You JX, Wen MZ, Wang JB, Yang XT. Assessing volatile organic compounds exposure and chronic obstructive pulmonary diseases in US adults. Front Public Health. 2023;11:1210136.","journal-title":"Front Public Health"},{"key":"3165_CR22","volume-title":"IARC monographs on the evaluation of carcinogenic risks to humans","author":"International Agency for Research on Cancer","year":"2021","unstructured":"International Agency for Research on Cancer. Acrolein, Crotonaldehyde, and Arecoline. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 128. Lyon, FR: IARC; 2021."},{"key":"3165_CR23","unstructured":"U.S. Department of Health and Human Services. Public Health Service Agency for Toxic Substances and Disease Registry. Toxicological profile for acrolein 2007 (Available at: https:\/\/www.atsdr.cdc.gov\/toxprofiles\/tp124.pdf, accessed: 8 December 2023)."},{"issue":"4","key":"3165_CR24","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1021\/tx200536w","volume":"25","author":"HJ Haussmann","year":"2012","unstructured":"Haussmann HJ. Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chem Res Toxicol. 2012;25(4):794\u2013810.","journal-title":"Chem Res Toxicol"},{"issue":"4","key":"3165_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/tc.12.4.424","volume":"12","author":"J Fowles","year":"2003","unstructured":"Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control. 2003;12(4):424\u201330.","journal-title":"Tob Control"},{"key":"3165_CR26","doi-asserted-by":"publisher","first-page":"107401","DOI":"10.1016\/j.envint.2022.107401","volume":"167","author":"B Wang","year":"2022","unstructured":"Wang B, Yu L, Liu W, Yang M, Fan L, Zhou M, et al. Cross-sectional and longitudinal associations of acrolein exposure with pulmonary function alteration: assessing the potential roles of oxidative DNA damage, inflammation, and pulmonary epithelium injury in a general adult population. Environ Int. 2022;167:107401.","journal-title":"Environ Int"},{"issue":"1\u20134","key":"3165_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10937404.2019.1633718","volume":"22","author":"MI Banton","year":"2019","unstructured":"Banton MI, Bus JS, Collins JJ, Delzell E, Gelbke HP, Kester JE, et al. Evaluation of potential health effects associated with occupational and environmental exposure to styrene - an update. J Toxicol Environ Health B Crit Rev. 2019;22(1\u20134):1\u2013130.","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"3165_CR28","doi-asserted-by":"publisher","first-page":"153730","DOI":"10.1016\/j.scitotenv.2022.153730","volume":"823","author":"Z Yuan","year":"2022","unstructured":"Yuan Z, Nag R, Cummins E. Human health concerns regarding microplastics in the aquatic environment - From marine to food systems. Sci Total Environ. 2022;823:153730.","journal-title":"Sci Total Environ"},{"key":"3165_CR29","first-page":"227","volume-title":"IARC monographs on the evaluation of carcinogenic risks to humans","author":"International Agency for Research on Cancer","year":"2000","unstructured":"International Agency for Research on Cancer. Some industrial chemicals. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 77. Lyon, FR: IARC; 2000. pp. 227\u201366."},{"key":"3165_CR30","first-page":"32","volume-title":"IARC monographs on the evaluation of carcinogenic risks to humans","author":"International Agency for Research on Cancer","year":"2019","unstructured":"International Agency for Research on Cancer. Styrene, styrene-7,8-oxide, and Quinoline. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 121. Lyon, FR: IARC; 2019. pp. 32\u20135."},{"issue":"2","key":"3165_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ajim.22655","volume":"60","author":"RJ Nett","year":"2017","unstructured":"Nett RJ, Cox-Ganser JM, Hubbs AF, Ruder AM, Cummings KJ, Huang YT, Kreiss K. Non-malignant respiratory disease among workers in industries using styrene-A review of the evidence. Am J Ind Med. 2017;60(2):163\u201380.","journal-title":"Am J Ind Med"},{"issue":"2","key":"3165_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/oemed-2015-102990","volume":"73","author":"AM Ruder","year":"2016","unstructured":"Ruder AM, Meyers AR, Bertke SJ. Mortality among styrene-exposed workers in the reinforced plastic boatbuilding industry. Occup Environ Med. 2016;73(2):97\u2013102.","journal-title":"Occup Environ Med"},{"issue":"11","key":"3165_CR33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/JOM.0000000000001688","volume":"61","author":"N Sathiakumar","year":"2019","unstructured":"Sathiakumar N, Tipre M, Leader M, Brill I, Delzell E. Mortality among men and women in the North American synthetic rubber industry, 1943 to 2009. J Occup Environ Med. 2019;61(11):887\u201397.","journal-title":"J Occup Environ Med"},{"issue":"9","key":"3165_CR34","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/aje\/kwab108","volume":"190","author":"SJ Bertke","year":"2021","unstructured":"Bertke SJ, Keil AP, Daniels RD. Lung Cancer mortality and styrene exposure in the Reinforced-Plastics boatbuilding industry: evaluation of healthy worker survivor Bias. Am J Epidemiol. 2021;190(9):1784\u201392.","journal-title":"Am J Epidemiol"},{"key":"3165_CR35","doi-asserted-by":"crossref","unstructured":"Mendy A, Merianos AL, Mersha TB, Mahabee-Gittens EM. Blood volatile organic compounds associated with non-reversible and reversible airflow obstruction in US adults. Eur Respir J. 2022;60(5).","DOI":"10.1183\/13993003.01185-2022"},{"issue":"3","key":"3165_CR36","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/EDE.0000000000001469","volume":"33","author":"KM O\u2019Brien","year":"2022","unstructured":"O\u2019Brien KM, Lawrence KG, Keil AP. The case for case-Cohort: an applied epidemiologist\u2019s guide to reframing case-Cohort studies to improve usability and flexibility. Epidemiology. 2022;33(3):354\u201361.","journal-title":"Epidemiology"},{"issue":"2","key":"3165_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/0008-5472.CAN-13-3178","volume":"74","author":"JM Yuan","year":"2014","unstructured":"Yuan JM, Butler LM, Stepanov I, Hecht SS. Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer. Cancer Res. 2014;74(2):401\u201311.","journal-title":"Cancer Res"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03165-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T18:05:41Z","timestamp":1741197941000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03165-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3165"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03165-1","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethical review committees of the U.S. National Cancer Institute (protocol number: 07CN120), the Tehran University of Medical Sciences, and the International Agency for Research on Cancer (IARC). All participants provided a written informed consent. This study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Department of Health and Human Services or any of its affiliated institutions or agencies. Use of trade names and commercial sources is for identification only and does not constitute endorsement by the U.S. Department of Health and Human Services, or the U.S. Centers for Disease Control and Prevention (Division of Laboratory Sciences).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"88"}}